Bioatla Correlations

BCAB Stock  USD 0.72  0.06  7.69%   
The current 90-days correlation between Bioatla and Celularity is 0.03 (i.e., Significant diversification). The correlation of Bioatla is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bioatla Correlation With Market

Good diversification

The correlation between Bioatla and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

Moving against Bioatla Stock

  0.45688578 Shanghai Allist PharPairCorr
  0.4VANI Vivani MedicalPairCorr
  0.34DTIL Precision BioSciencesPairCorr
  0.33EQ EquilliumPairCorr
  0.39ELUT Elutia IncPairCorr
  0.37ELDN Eledon PharmaceuticalsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MRSNANVS
VERUGBIO
VERUBTAI
BTAICELU
ANVSPYPD
GBIOBTAI
  

High negative correlations

VERUPYPD
MRSNVERU
BTAIPYPD
VERUANVS
PYPDCELU
GBIOANVS

Risk-Adjusted Indicators

There is a big difference between Bioatla Stock performing well and Bioatla Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bioatla's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CELU  3.76 (0.82) 0.00 (0.55) 0.00 
 10.29 
 26.97 
PYPD  1.90  0.35  0.15  0.33  1.98 
 4.94 
 12.71 
ANVS  5.46  0.97  0.15  0.73  6.05 
 14.79 
 41.06 
RVPH  8.42  0.53  0.05  0.31  10.75 
 21.82 
 81.87 
EVAX  7.39  0.57  0.06  0.51  9.06 
 19.62 
 69.70 
BTAI  4.10 (0.76) 0.00 (0.62) 0.00 
 8.17 
 21.75 
MURA  0.41 (0.04) 0.00 (0.48) 0.00 
 0.96 
 4.78 
GBIO  2.00 (0.11)(0.03) 0.00  2.49 
 4.75 
 12.30 
VERU  3.41 (0.91) 0.00 (1.06) 0.00 
 5.78 
 22.48 
MRSN  7.57  4.43  0.86 (0.38) 2.38 
 7.25 
 210.61 

Bioatla Corporate Management

Gerhard FreySenior DevelopmentProfile
Cathy ChangSenior DevelopmentProfile
Christian CPAController OfficerProfile
Sheri LydickChief OfficerProfile
Philippe MartinChief OperationsProfile
Monica SullivanSenior ContractsProfile
Christian VasquezController OfficerProfile